Modified Patient Stem Cells as Prelude to Autologous Treatment of Muscular Dystrophy

K.E. Davies, Miranda Grounds

    Research output: Contribution to journalLetter

    5 Citations (Scopus)

    Abstract

    Duchenne muscular dystrophy is a devastating muscle wasting disease for which there is no effective treatment. In this issue of Cell Stem Cell, Benchaouir et al. (2007) demonstrate the delivery of genetically corrected CD133+ patient cells into mice, suggesting a new potential avenue for autologous cell therapy.
    Original languageEnglish
    Pages (from-to)595-560
    JournalCell Stem Cell
    Volume1
    Issue number6
    DOIs
    Publication statusPublished - 2007

    Fingerprint

    Dive into the research topics of 'Modified Patient Stem Cells as Prelude to Autologous Treatment of Muscular Dystrophy'. Together they form a unique fingerprint.

    Cite this